Confirmation of guidance to vaccination centres

The MHRA has produced confirmed guidance on managing allergic reactions in vaccination centres

This follows the news that two patients suffered anaphylaxis after receiving the Pfizer BioNTech vaccine.

Dr June Raine, Chief Executive of MHRA stated that “we convened an Expert Group of the Commission on Human Medicines”. She noted that “any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine.”

Additionally, it is being recommended that recipients of the vaccine should be monitored for 15 minutes after their jab.

The updated guidance does state that the health professionals overseeing the vaccination service must be trained to recognise an anaphylactic reaction and be familiar with techniques for resuscitation of a patient with anaphylaxis.

To read the full press release, please click here.

For registration, or any login issues, please visit our login page.